Thu, February 15, 2024
Wed, February 14, 2024
Tue, February 13, 2024
Mon, February 12, 2024

Brian Abrahams Maintained (BIIB) at Buy with Decreased Target to $364 on, Feb 14th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-364-on-feb-14th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Brian Abrahams of RBC Capital, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $379 to $364 on, Feb 14th, 2024.

Brian has made no other calls on BIIB in the last 4 months.



There are 6 other peers that have a rating on BIIB. Out of the 6 peers that are also analyzing BIIB, 2 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Colin Bristow of "UBS" Downgraded from Strong Buy to Hold and Decreased Target to $276 on, Thursday, January 25th, 2024
  • Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $239 on, Thursday, November 9th, 2023


These are the ratings of the 4 analyists that currently disagree with Brian


  • Eric Schmidt of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $311 on, Wednesday, December 20th, 2023
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $287 on, Thursday, December 14th, 2023
  • Danielle Brill of "Raymond James" Upgraded from Hold to Buy and Held Target at $283 on, Thursday, December 7th, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $373 on, Friday, November 10th, 2023

Publication Contributing Sources